Anixa Biosciences Statistics
NASDAQ: ANIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.44-0.16 (-6.15%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Anixa Biosciences by the numbers
Anixa Biosciences has a market capitalization of $84.8 million based on 34.76M shares outstanding. With trailing EPS of $-0.32, Anixa Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.5% below its 50-day average and 17.3% below its 200-day average.
Average daily trading volume is 282.29K shares, or about $688,785 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANIX valuation vs. peer median
| Metric | ANIX | Peer median | Difference |
|---|---|---|---|
| Market cap | $84.82M | $84.71M | +0% |
| Avg. volume | 282.29K | 556.08K | -49% |
Peer median across 8 companies: UPB, EQ, OGI, HURA, RTSN, CPIX, NKTX, TLSA.
Valuation
- Market cap
- $84.82M
- EPS (TTM)
- $-0.32
- Shares outstanding
- 34.76M
Price and trading
- Previous close
- 2.60
- Open
- 2.55
- Day range
- 2.40 – 2.59
- 52-week range
- 2.32 – 5.46
- 52-week change
- -43.78%
- Beta
- —
- Volume
- 355.05K
- Average volume
- 282.29K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 9, 2026
Additional statistics
- Market Cap
- 84.82M
- Forward Pe
- -7.87
- Eps
- -0.32
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.46
- Week52 Low
- 2.32
- Avg Volume
- 282.29K
- Shares Outstanding
- 34.76M
- Ma50
- 2.85
- Ma200
- 2.95
- Earnings Date
- Sep 9, 2026
- Pct From52w High
- -55.31%
- Pct From52w Low
- 5.17%